nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP2C9—cardial valve—dilated cardiomyopathy	0.0369	0.202	CbGeAlD
Perphenazine—HTR7—pulmonary artery—dilated cardiomyopathy	0.0197	0.108	CbGeAlD
Perphenazine—CALM1—sympathetic nervous system—dilated cardiomyopathy	0.0196	0.108	CbGeAlD
Perphenazine—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.0192	0.105	CbGeAlD
Perphenazine—Incontinence—Furosemide—dilated cardiomyopathy	0.0146	0.0411	CcSEcCtD
Perphenazine—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0145	0.0407	CcSEcCtD
Perphenazine—Hypotensive—Furosemide—dilated cardiomyopathy	0.014	0.0393	CcSEcCtD
Perphenazine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0123	0.0673	CbGeAlD
Perphenazine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.012	0.0655	CbGeAlD
Perphenazine—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.0107	0.03	CcSEcCtD
Perphenazine—Moricizine—SCN5A—dilated cardiomyopathy	0.00884	0.583	CrCbGaD
Perphenazine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00839	0.0236	CcSEcCtD
Perphenazine—Lethargy—Spironolactone—dilated cardiomyopathy	0.00695	0.0195	CcSEcCtD
Perphenazine—Cholestasis—Furosemide—dilated cardiomyopathy	0.00672	0.0189	CcSEcCtD
Perphenazine—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00659	0.0185	CcSEcCtD
Perphenazine—Ataxia—Spironolactone—dilated cardiomyopathy	0.0064	0.018	CcSEcCtD
Perphenazine—Glycosuria—Furosemide—dilated cardiomyopathy	0.0063	0.0177	CcSEcCtD
Perphenazine—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00597	0.0168	CcSEcCtD
Perphenazine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00583	0.0164	CcSEcCtD
Perphenazine—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00581	0.0163	CcSEcCtD
Perphenazine—CALM3—cardiac ventricle—dilated cardiomyopathy	0.00537	0.0294	CbGeAlD
Perphenazine—Throat sore—Lisinopril—dilated cardiomyopathy	0.00531	0.0149	CcSEcCtD
Perphenazine—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00527	0.0148	CcSEcCtD
Perphenazine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00525	0.0148	CcSEcCtD
Perphenazine—CALM3—myocardium—dilated cardiomyopathy	0.00505	0.0277	CbGeAlD
Perphenazine—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.00495	0.327	CrCbGaD
Perphenazine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0049	0.0138	CcSEcCtD
Perphenazine—Urine output increased—Furosemide—dilated cardiomyopathy	0.00461	0.013	CcSEcCtD
Perphenazine—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00436	0.0123	CcSEcCtD
Perphenazine—Polyuria—Furosemide—dilated cardiomyopathy	0.00422	0.0119	CcSEcCtD
Perphenazine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00422	0.0119	CcSEcCtD
Perphenazine—CALM2—cardiac ventricle—dilated cardiomyopathy	0.00422	0.0231	CbGeAlD
Perphenazine—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00421	0.0118	CcSEcCtD
Perphenazine—CALM1—cardiac ventricle—dilated cardiomyopathy	0.0042	0.023	CbGeAlD
Perphenazine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0041	0.0115	CcSEcCtD
Perphenazine—CALM2—myocardium—dilated cardiomyopathy	0.00396	0.0217	CbGeAlD
Perphenazine—CALM1—myocardium—dilated cardiomyopathy	0.00395	0.0216	CbGeAlD
Perphenazine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00394	0.0111	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00393	0.011	CcSEcCtD
Perphenazine—AOX1—heart—dilated cardiomyopathy	0.00391	0.0214	CbGeAlD
Perphenazine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00383	0.0108	CcSEcCtD
Perphenazine—Lethargy—Furosemide—dilated cardiomyopathy	0.00378	0.0106	CcSEcCtD
Perphenazine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00372	0.0105	CcSEcCtD
Perphenazine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00367	0.0103	CcSEcCtD
Perphenazine—Photophobia—Lisinopril—dilated cardiomyopathy	0.0036	0.0101	CcSEcCtD
Perphenazine—CALM3—heart—dilated cardiomyopathy	0.00352	0.0193	CbGeAlD
Perphenazine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00352	0.0099	CcSEcCtD
Perphenazine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00338	0.00951	CcSEcCtD
Perphenazine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00337	0.00949	CcSEcCtD
Perphenazine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00335	0.00941	CcSEcCtD
Perphenazine—AOX1—cardiac atrium—dilated cardiomyopathy	0.00335	0.0183	CbGeAlD
Perphenazine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00327	0.00919	CcSEcCtD
Perphenazine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00317	0.00891	CcSEcCtD
Perphenazine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00317	0.0089	CcSEcCtD
Perphenazine—Eczema—Lisinopril—dilated cardiomyopathy	0.00309	0.0087	CcSEcCtD
Perphenazine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00308	0.00866	CcSEcCtD
Perphenazine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00305	0.00858	CcSEcCtD
Perphenazine—CALM3—cardiac atrium—dilated cardiomyopathy	0.00301	0.0165	CbGeAlD
Perphenazine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00298	0.00837	CcSEcCtD
Perphenazine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00292	0.00822	CcSEcCtD
Perphenazine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00289	0.00812	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00287	0.00807	CcSEcCtD
Perphenazine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00286	0.00803	CcSEcCtD
Perphenazine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00285	0.00801	CcSEcCtD
Perphenazine—CALM2—heart—dilated cardiomyopathy	0.00277	0.0152	CbGeAlD
Perphenazine—CALM1—heart—dilated cardiomyopathy	0.00275	0.0151	CbGeAlD
Perphenazine—HTR7—heart—dilated cardiomyopathy	0.00269	0.0147	CbGeAlD
Perphenazine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00266	0.00749	CcSEcCtD
Perphenazine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00266	0.00748	CcSEcCtD
Perphenazine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00265	0.00744	CcSEcCtD
Perphenazine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00264	0.00743	CcSEcCtD
Perphenazine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00261	0.00735	CcSEcCtD
Perphenazine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00254	0.00714	CcSEcCtD
Perphenazine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00247	0.00693	CcSEcCtD
Perphenazine—Asthma—Lisinopril—dilated cardiomyopathy	0.0024	0.00675	CcSEcCtD
Perphenazine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00238	0.00669	CcSEcCtD
Perphenazine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00237	0.00666	CcSEcCtD
Perphenazine—CALM2—cardiac atrium—dilated cardiomyopathy	0.00237	0.013	CbGeAlD
Perphenazine—CALM1—cardiac atrium—dilated cardiomyopathy	0.00236	0.0129	CbGeAlD
Perphenazine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00229	0.00644	CcSEcCtD
Perphenazine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00228	0.00641	CcSEcCtD
Perphenazine—Erythema—Furosemide—dilated cardiomyopathy	0.00223	0.00627	CcSEcCtD
Perphenazine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00221	0.00622	CcSEcCtD
Perphenazine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00219	0.00617	CcSEcCtD
Perphenazine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00217	0.00609	CcSEcCtD
Perphenazine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00215	0.00603	CcSEcCtD
Perphenazine—Vision blurred—Furosemide—dilated cardiomyopathy	0.0021	0.00591	CcSEcCtD
Perphenazine—Headache—Spironolactone—dilated cardiomyopathy	0.0021	0.00589	CcSEcCtD
Perphenazine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00209	0.00587	CcSEcCtD
Perphenazine—CYP2B6—heart—dilated cardiomyopathy	0.00206	0.0113	CbGeAlD
Perphenazine—Agitation—Furosemide—dilated cardiomyopathy	0.00205	0.00576	CcSEcCtD
Perphenazine—CYP2C9—heart—dilated cardiomyopathy	0.00204	0.0112	CbGeAlD
Perphenazine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.002	0.00562	CcSEcCtD
Perphenazine—Leukopenia—Furosemide—dilated cardiomyopathy	0.002	0.00561	CcSEcCtD
Perphenazine—ADRA2A—heart—dilated cardiomyopathy	0.00197	0.0108	CbGeAlD
Perphenazine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00196	0.0055	CcSEcCtD
Perphenazine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00189	0.00533	CcSEcCtD
Perphenazine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00186	0.00522	CcSEcCtD
Perphenazine—Confusional state—Furosemide—dilated cardiomyopathy	0.00184	0.00516	CcSEcCtD
Perphenazine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00182	0.00512	CcSEcCtD
Perphenazine—Shock—Furosemide—dilated cardiomyopathy	0.00179	0.00504	CcSEcCtD
Perphenazine—Anorexia—Furosemide—dilated cardiomyopathy	0.00174	0.00488	CcSEcCtD
Perphenazine—Hypotension—Furosemide—dilated cardiomyopathy	0.0017	0.00478	CcSEcCtD
Perphenazine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00169	0.00925	CbGeAlD
Perphenazine—HTR2A—heart—dilated cardiomyopathy	0.00168	0.00919	CbGeAlD
Perphenazine—Erythema—Lisinopril—dilated cardiomyopathy	0.00167	0.00471	CcSEcCtD
Perphenazine—Somnolence—Furosemide—dilated cardiomyopathy	0.00162	0.00455	CcSEcCtD
Perphenazine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00161	0.00452	CcSEcCtD
Perphenazine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00158	0.00445	CcSEcCtD
Perphenazine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00158	0.00444	CcSEcCtD
Perphenazine—Pain—Furosemide—dilated cardiomyopathy	0.00156	0.00438	CcSEcCtD
Perphenazine—Constipation—Furosemide—dilated cardiomyopathy	0.00156	0.00438	CcSEcCtD
Perphenazine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00153	0.0043	CcSEcCtD
Perphenazine—Syncope—Lisinopril—dilated cardiomyopathy	0.0015	0.00422	CcSEcCtD
Perphenazine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.0015	0.00421	CcSEcCtD
Perphenazine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00147	0.00414	CcSEcCtD
Perphenazine—Cough—Lisinopril—dilated cardiomyopathy	0.00146	0.00411	CcSEcCtD
Perphenazine—Urticaria—Furosemide—dilated cardiomyopathy	0.00145	0.00407	CcSEcCtD
Perphenazine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00144	0.00405	CcSEcCtD
Perphenazine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00139	0.00392	CcSEcCtD
Perphenazine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00138	0.00387	CcSEcCtD
Perphenazine—Aripiprazole—ADRB1—dilated cardiomyopathy	0.00137	0.0905	CrCbGaD
Perphenazine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00137	0.00384	CcSEcCtD
Perphenazine—Infection—Lisinopril—dilated cardiomyopathy	0.00136	0.00382	CcSEcCtD
Perphenazine—Shock—Lisinopril—dilated cardiomyopathy	0.00134	0.00378	CcSEcCtD
Perphenazine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00134	0.00377	CcSEcCtD
Perphenazine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00133	0.00375	CcSEcCtD
Perphenazine—Anorexia—Lisinopril—dilated cardiomyopathy	0.0013	0.00366	CcSEcCtD
Perphenazine—Pruritus—Furosemide—dilated cardiomyopathy	0.00129	0.00362	CcSEcCtD
Perphenazine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00128	0.00359	CcSEcCtD
Perphenazine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00125	0.0035	CcSEcCtD
Perphenazine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00124	0.00347	CcSEcCtD
Perphenazine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00122	0.00342	CcSEcCtD
Perphenazine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00121	0.00341	CcSEcCtD
Perphenazine—Dizziness—Furosemide—dilated cardiomyopathy	0.0012	0.00339	CcSEcCtD
Perphenazine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00119	0.00334	CcSEcCtD
Perphenazine—Pain—Lisinopril—dilated cardiomyopathy	0.00117	0.00328	CcSEcCtD
Perphenazine—Constipation—Lisinopril—dilated cardiomyopathy	0.00117	0.00328	CcSEcCtD
Perphenazine—Headache—Furosemide—dilated cardiomyopathy	0.00114	0.00321	CcSEcCtD
Perphenazine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00109	0.00305	CcSEcCtD
Perphenazine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00108	0.00304	CcSEcCtD
Perphenazine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00101	0.00283	CcSEcCtD
Perphenazine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000967	0.00272	CcSEcCtD
Perphenazine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000935	0.00263	CcSEcCtD
Perphenazine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000904	0.00254	CcSEcCtD
Perphenazine—Headache—Lisinopril—dilated cardiomyopathy	0.000856	0.00241	CcSEcCtD
Perphenazine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.05e-05	0.000135	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	6.05e-05	0.000135	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.03e-05	0.000135	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6e-05	0.000134	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6e-05	0.000134	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.98e-05	0.000134	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.97e-05	0.000134	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.95e-05	0.000133	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.94e-05	0.000133	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.89e-05	0.000132	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.89e-05	0.000132	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.88e-05	0.000132	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.84e-05	0.000131	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.84e-05	0.000131	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.79e-05	0.00013	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	5.79e-05	0.00013	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.78e-05	0.000129	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.74e-05	0.000129	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.74e-05	0.000129	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.73e-05	0.000128	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.73e-05	0.000128	CbGpPWpGaD
Perphenazine—CALM3—Signaling by NGF—EGFR—dilated cardiomyopathy	5.71e-05	0.000128	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.71e-05	0.000128	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.7e-05	0.000128	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.69e-05	0.000127	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.69e-05	0.000127	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.64e-05	0.000126	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.63e-05	0.000126	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.62e-05	0.000126	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.59e-05	0.000125	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.59e-05	0.000125	CbGpPWpGaD
Perphenazine—CALM2—Signaling by NGF—EGFR—dilated cardiomyopathy	5.53e-05	0.000124	CbGpPWpGaD
Perphenazine—CALM1—Signaling by NGF—EGFR—dilated cardiomyopathy	5.53e-05	0.000124	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.52e-05	0.000123	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.5e-05	0.000123	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.49e-05	0.000123	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.45e-05	0.000122	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.43e-05	0.000121	CbGpPWpGaD
Perphenazine—AOX1—Disease—EGFR—dilated cardiomyopathy	5.42e-05	0.000121	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.38e-05	0.00012	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.37e-05	0.00012	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	5.35e-05	0.00012	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.34e-05	0.00012	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.33e-05	0.000119	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—RAF1—dilated cardiomyopathy	5.28e-05	0.000118	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.27e-05	0.000118	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	5.26e-05	0.000118	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.25e-05	0.000118	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	5.25e-05	0.000118	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.22e-05	0.000117	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.22e-05	0.000117	CbGpPWpGaD
Perphenazine—CALM3—Immune System—ITGB1—dilated cardiomyopathy	5.19e-05	0.000116	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.19e-05	0.000116	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.19e-05	0.000116	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.17e-05	0.000116	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.16e-05	0.000116	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.11e-05	0.000114	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—RAF1—dilated cardiomyopathy	5.11e-05	0.000114	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—RAF1—dilated cardiomyopathy	5.11e-05	0.000114	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	5.09e-05	0.000114	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.08e-05	0.000114	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	5.08e-05	0.000114	CbGpPWpGaD
Perphenazine—CALM2—Immune System—ITGB1—dilated cardiomyopathy	5.02e-05	0.000113	CbGpPWpGaD
Perphenazine—CALM1—Immune System—ITGB1—dilated cardiomyopathy	5.02e-05	0.000113	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.01e-05	0.000112	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.91e-05	0.00011	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.9e-05	0.00011	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	4.86e-05	0.000109	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.86e-05	0.000109	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	4.85e-05	0.000109	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.85e-05	0.000109	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.85e-05	0.000108	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.82e-05	0.000108	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.79e-05	0.000107	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.78e-05	0.000107	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.77e-05	0.000107	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.77e-05	0.000107	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—RAF1—dilated cardiomyopathy	4.75e-05	0.000106	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.7e-05	0.000105	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.65e-05	0.000104	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.61e-05	0.000103	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.61e-05	0.000103	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.61e-05	0.000103	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.61e-05	0.000103	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—RAF1—dilated cardiomyopathy	4.6e-05	0.000103	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—RAF1—dilated cardiomyopathy	4.6e-05	0.000103	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.57e-05	0.000102	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—RAF1—dilated cardiomyopathy	4.56e-05	0.000102	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.49e-05	0.0001	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.43e-05	9.92e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD36—dilated cardiomyopathy	4.43e-05	9.92e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.42e-05	9.9e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.42e-05	9.9e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—RAF1—dilated cardiomyopathy	4.42e-05	9.89e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—RAF1—dilated cardiomyopathy	4.42e-05	9.89e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.42e-05	9.89e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.41e-05	9.86e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.38e-05	9.8e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AGT—dilated cardiomyopathy	4.37e-05	9.78e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.29e-05	9.61e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.29e-05	9.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.29e-05	9.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD36—dilated cardiomyopathy	4.29e-05	9.6e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD36—dilated cardiomyopathy	4.29e-05	9.6e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.26e-05	9.53e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.23e-05	9.46e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AGT—dilated cardiomyopathy	4.22e-05	9.46e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AGT—dilated cardiomyopathy	4.22e-05	9.46e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.2e-05	9.41e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.19e-05	9.38e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.19e-05	9.38e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	4.18e-05	9.36e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.18e-05	9.36e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—RAC1—dilated cardiomyopathy	4.18e-05	9.35e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.17e-05	9.33e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.15e-05	9.3e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.15e-05	9.3e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.14e-05	9.28e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—RAC1—dilated cardiomyopathy	4.04e-05	9.04e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—RAC1—dilated cardiomyopathy	4.04e-05	9.04e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.02e-05	8.99e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.91e-05	8.76e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.91e-05	8.75e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	3.86e-05	8.63e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—RAC1—dilated cardiomyopathy	3.85e-05	8.63e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.81e-05	8.53e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.76e-05	8.43e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	3.75e-05	8.41e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	3.74e-05	8.38e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—RAC1—dilated cardiomyopathy	3.73e-05	8.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—RAC1—dilated cardiomyopathy	3.73e-05	8.35e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.71e-05	8.31e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.67e-05	8.21e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.66e-05	8.19e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.65e-05	8.17e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.64e-05	8.16e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	3.61e-05	8.09e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.6e-05	8.06e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	3.6e-05	8.05e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.59e-05	8.04e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	3.58e-05	8.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.55e-05	7.94e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.55e-05	7.94e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	3.52e-05	7.88e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—GPX1—dilated cardiomyopathy	3.52e-05	7.88e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.48e-05	7.79e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—CD36—dilated cardiomyopathy	3.43e-05	7.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—GPX1—dilated cardiomyopathy	3.4e-05	7.62e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—GPX1—dilated cardiomyopathy	3.4e-05	7.62e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	3.38e-05	7.57e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	3.37e-05	7.55e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.37e-05	7.54e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	3.37e-05	7.54e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.36e-05	7.53e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.36e-05	7.53e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.32e-05	7.44e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—CD36—dilated cardiomyopathy	3.31e-05	7.42e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—CD36—dilated cardiomyopathy	3.31e-05	7.42e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	3.3e-05	7.4e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.27e-05	7.33e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—EGFR—dilated cardiomyopathy	3.26e-05	7.3e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.25e-05	7.28e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.24e-05	7.27e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	3.17e-05	7.1e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	3.16e-05	7.07e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—EGFR—dilated cardiomyopathy	3.15e-05	7.06e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—EGFR—dilated cardiomyopathy	3.15e-05	7.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—EGFR—dilated cardiomyopathy	3.13e-05	7.01e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.11e-05	6.96e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	3.1e-05	6.94e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AGT—dilated cardiomyopathy	3.08e-05	6.91e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	3.06e-05	6.85e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.03e-05	6.78e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—EGFR—dilated cardiomyopathy	3.03e-05	6.78e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—EGFR—dilated cardiomyopathy	3.03e-05	6.78e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.99e-05	6.69e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AGT—dilated cardiomyopathy	2.98e-05	6.68e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AGT—dilated cardiomyopathy	2.98e-05	6.68e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	2.98e-05	6.67e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.96e-05	6.62e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.93e-05	6.56e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.93e-05	6.56e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.9e-05	6.5e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.9e-05	6.49e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.89e-05	6.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.89e-05	6.47e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.88e-05	6.45e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.83e-05	6.33e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—RAF1—dilated cardiomyopathy	2.77e-05	6.2e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	2.73e-05	6.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—RAC1—dilated cardiomyopathy	2.7e-05	6.04e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	2.68e-05	6.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—RAF1—dilated cardiomyopathy	2.68e-05	6e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—RAF1—dilated cardiomyopathy	2.68e-05	6e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	2.66e-05	5.96e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.61e-05	5.85e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.61e-05	5.85e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AGT—dilated cardiomyopathy	2.58e-05	5.77e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—RAF1—dilated cardiomyopathy	2.56e-05	5.72e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.54e-05	5.7e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.51e-05	5.62e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.5e-05	5.6e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.5e-05	5.59e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.5e-05	5.59e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AGT—dilated cardiomyopathy	2.49e-05	5.59e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AGT—dilated cardiomyopathy	2.49e-05	5.59e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	2.49e-05	5.58e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	2.48e-05	5.56e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—RAF1—dilated cardiomyopathy	2.47e-05	5.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—RAF1—dilated cardiomyopathy	2.47e-05	5.54e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.45e-05	5.48e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.43e-05	5.43e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.4e-05	5.36e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	2.31e-05	5.18e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	2.31e-05	5.17e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.28e-05	5.1e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.2e-05	4.93e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.19e-05	4.91e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.18e-05	4.89e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.16e-05	4.83e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.15e-05	4.82e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.13e-05	4.77e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.08e-05	4.65e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.07e-05	4.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.01e-05	4.5e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.01e-05	4.5e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.99e-05	4.46e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.96e-05	4.39e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—EGFR—dilated cardiomyopathy	1.9e-05	4.25e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	1.87e-05	4.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EGFR—dilated cardiomyopathy	1.84e-05	4.11e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EGFR—dilated cardiomyopathy	1.84e-05	4.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.79e-05	4.01e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EGFR—dilated cardiomyopathy	1.75e-05	3.92e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.73e-05	3.88e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.73e-05	3.88e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.71e-05	3.83e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.7e-05	3.81e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—dilated cardiomyopathy	1.7e-05	3.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—dilated cardiomyopathy	1.7e-05	3.8e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.64e-05	3.68e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.6e-05	3.58e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.5e-05	3.36e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.48e-05	3.31e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.48e-05	3.3e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.44e-05	3.22e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.35e-05	3.01e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.23e-05	2.75e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.19e-05	2.66e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.19e-05	2.66e-05	CbGpPWpGaD
